Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

631 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
G- and GM-CSF.
Middleton M, Thatcher N. Middleton M, et al. Int J Antimicrob Agents. 1998 May;10(2):91-3. doi: 10.1016/s0924-8579(98)00015-6. Int J Antimicrob Agents. 1998. PMID: 9716285 Review. No abstract available.
Dose intensity in small cell lung cancer.
Thatcher N, Lee SM, Woll PJ, Middleton M, Anderson H, Burt P, Stout R. Thatcher N, et al. Among authors: middleton m. Semin Oncol. 1998 Apr;25(2 Suppl 4):12-8; discussion 45-8. Semin Oncol. 1998. PMID: 9578057 Review.
Results of a multicenter randomized study to evaluate the safety and efficacy of combined immunotherapy with interleukin-2, interferon-{alpha}2b and histamine dihydrochloride versus dacarbazine in patients with stage IV melanoma.
Middleton M, Hauschild A, Thomson D, Anderson R, Burdette-Radoux S, Gehlsen K, Hellstrand K, Naredi P. Middleton M, et al. Ann Oncol. 2007 Oct;18(10):1691-7. doi: 10.1093/annonc/mdm331. Epub 2007 Aug 20. Ann Oncol. 2007. PMID: 17709802 Free article. Clinical Trial.
A two-part phase II study of cediranib in patients with advanced solid tumours: the effect of food on single-dose pharmacokinetics and an evaluation of safety, efficacy and imaging pharmacodynamics.
Mitchell CL, O'Connor JP, Roberts C, Watson Y, Jackson A, Cheung S, Evans J, Spicer J, Harris A, Kelly C, Rudman S, Middleton M, Fielding A, Tessier J, Young H, Parker GJ, Jayson GC. Mitchell CL, et al. Among authors: middleton m. Cancer Chemother Pharmacol. 2011 Sep;68(3):631-41. doi: 10.1007/s00280-010-1534-3. Epub 2010 Dec 1. Cancer Chemother Pharmacol. 2011. PMID: 21120480 Clinical Trial.
Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial.
Neoptolemos JP, Stocken DD, Bassi C, Ghaneh P, Cunningham D, Goldstein D, Padbury R, Moore MJ, Gallinger S, Mariette C, Wente MN, Izbicki JR, Friess H, Lerch MM, Dervenis C, Oláh A, Butturini G, Doi R, Lind PA, Smith D, Valle JW, Palmer DH, Buckels JA, Thompson J, McKay CJ, Rawcliffe CL, Büchler MW; European Study Group for Pancreatic Cancer. Neoptolemos JP, et al. JAMA. 2010 Sep 8;304(10):1073-81. doi: 10.1001/jama.2010.1275. JAMA. 2010. PMID: 20823433 Clinical Trial.
BDS Melanoma Guidelines.
Middleton M, Harris AL, Kurwa H, Millard P, Hollowood K, Cassell O. Middleton M, et al. Br J Dermatol. 2003 May;148(5):1081-2; author reply 1082. doi: 10.1046/j.1365-2133.2003.05349.x. Br J Dermatol. 2003. PMID: 12786860 No abstract available.
631 results